Skip to content
DraconiticResearch
Search Sources API
206,690 studies31 sourcesUpdated 10 min ago

Oncology

5,185 studies511 in 7 days2,486 in 30 days

Filters
Type
Date
Clear

Latest

5,185 studies

  1. LncRNA A1BGAS1 Serves as a Tumor Suppressor in Non-Small Cell Lung Cancer by Modulating the Expression of miR-3942-5P.
    Jiahui Du, Zhenhua Li, Chunqiang Wang +1
    Journal of biochemical and molecular toxicologyPeer-reviewedCC BY-NCFull textOncologyEurope PMCPMC
  2. The Place of Therapeutic Apheresis in Severe Immune-Related Adverse Events: A Scoping Review of Literature.
    C Vuillet, O Moranne, D Daubin +5
    Journal of clinical apheresisPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  3. Identification of TM4SF1 as a novel tumor-associated antigen in biliary tract cancers targetable by CAR-T cell therapy
    L. Nuniz, J. H. Pham, J. Jacques +13
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  4. Persistent Malignant Stem Cells Drive Relapse After Transplantation in the Myelodysplastic Neoplasms
    B. Kroger, R. Tamari, C. Gurnari +25
    bioRxivPreprintAll rights reservedFull textOncologybioRxivPMC
  5. Targeting the sinusoidal-to-capillarized transition to normalize vessels in breast cancer liver metastasis
    H.-Y. Huang, C. Zhao, X.-N. Zheng +2
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  6. Customizable bead-based platform for EV surface protein immunocapture and detection in plasma
    H. S. Ilamathi, M. C. Mesa, M. O. Mowoe +8
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  7. Gene context shapes spatial organization and transcriptional heterogeneity of extrachromosomal DNA in cancer cells
    L. Frank, G. Marinopoulou, R. H. Medema
    bioRxivPreprintCC BYFull textOncologybioRxiv
  8. Activated ADAM10 targeting antibody 1H5 suppresses NOTCH-driven glioma progenitors
    U. Tosi, G. Ghita, N. Saha +5
    bioRxivPreprintCC BY-NDFull textOncologybioRxiv
  9. Lineage-mixed neurodevelopmental programs in pediatric sarcomas nominate tumor-selective surface antigen pairs.
    Alessandro Davini, Xueying Liu, Jackie L. Norrie +8
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxivPMC
  10. Glioblastoma Hijacks Astrocyte Ribosomes to Feul Malignancy through Translatome Reprogramming
    X. Wu, C. Zheng, L. Chen +17
    bioRxivPreprintCC BYFull textOncologybioRxiv
  11. Unequal recovery of health facility visits in hospitals and township health centres after COVID-19 disruption in Henan Province, China, 2014–2024: a time-series study
    Xin Tan, Yu Hua, Yanwei Ma +1
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textOncologyCrossref
  12. Latent profile analysis of psychological capital and its association with quality of life in colorectal cancer patients undergoing chemotherapy
    Qiqi He, Jiuqun Li, Xiaohang Su
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textOncologyCrossref
  13. Long-chain acyl-CoA synthetases in female reproductive diseases: isoform-specific regulation of lipid metabolism, ferroptosis, and inflammatory signaling
    Shanyuan Jin, Lin Guo, Zishuo Wu +4
    Frontiers in EndocrinologyPeer-reviewedCC BY 4.0OncologyCrossref
  14. Case Report: Metachronous multiple primary neoplasms in a carrier of germline MSH2 c.958dupA Lynch syndrome
    Liqiong Wang, Ping Li, Duanlin Hu +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyCrossref
  15. Psychological distress as a host-state factor in cancer immunotherapy: clinical associations, neuroendocrine mechanisms, and future trial design
    Guanwen Lin, Zhilin Luo
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyCrossref
  16. When should bladder cancer prompt evaluation for Lynch syndrome? An evidence-informed clinical framework
    Nicola Fazaa, Maya Gofer, Etan Eigner +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyCrossref
  17. Multiple myeloma bone disease models with integrated bone marrow adipose tissue for advancing personalized medicine
    Drenka Trivanović, Slavko Mojsilović, Nikola Bogosavljević +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyCrossref
  18. Mortality trends and high-risk subgroups in hematologic malignancy-associated pulmonary embolism: a population-based analysis with complementary clinical data
    Xi Quan, Ping Zhang, Nan Zhang +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  19. Global research trends and hotspots in cancer-related anemia from 2010 to 2025: a multidatabase bibliometric analysis
    Longjun Huang, Luyang Chi, Jiahao Sheng +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  20. Progressive multifocal leukoencephalopathy, bispecific antibodies, and multiple myeloma: a case report and systematic review of the literature
    Marina Tzanni, Panagiotis Polyzoidis, Konstantinos Angelopoulos +9
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  21. Successful salvage therapy with glofitamab followed by selinexor maintenance in an elderly patient with primary refractory diffuse large b-cell lymphoma harboring TP53 and CD58 mutations: a case report and literature review
    Yurong Zhang, Huan Liu, Liangliang Li +5
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  22. Dyadic associations between perceived family resilience and fear of disease progression among reproductive-age patients with cervical cancer and their spouses: a cross-sectional study
    Mei-Gui Peng, Zi-Yi Yuan, Long-Xian Liu +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  23. Case Report: Brain metastasis from cervical cancer treated with multimodal therapy
    Juntong Liu, Yunxin Wen, Yuyi Peng +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  24. Exploring the relationship between transferrin and progression-free survival in breast cancer patients after neoadjuvant therapy
    Jing He, Zhaoqi Zang, Jiaqin Zhou +6
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  25. All deaths follow recurrence, but not all recurrences are fatal: a retrospective cohort study of recurrence timing and survival after curative resection of hepatocellular carcinoma
    Qian Zhang, Ziyu Hou, Jie Zhang +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref